Dublin, Feb. 27, 2018 -- The "Epiomic Epidemioloy Series: Refractive Errors Forecast in 18 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.
The main role of the optical components of the eye is focusing rays of light on the retina. The situation in which parallel rays are focused properly is known as emmetropia. Various defects caused by the inability of the eye to converge the refracted rays on the retina are known as refractive errors (ametropias).
This report covers the features and epidemiology facts of hyperopia, myopia and presbyopia. The report provides the current prevalent population for refractive errors across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort.
In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the author's analysis team, several features of refractive errors patients, as well as the main comorbidities of the covered conditions have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of refractive errors include:
- Eye strain
- Headaches
- Glaucoma
- Cataracts
- Amblyopia
- Anisometropia
- Diabetes mellitus
- Arterial hypertension
Key Topics Covered:
- Introduction
- Cause Of The Disease
- Risk Factors & Prevention
- Diagnosis Of The Disease
- Variation By Geography/Ethnicity
- Disease Prognosis & Clinical Course
- Key Comorbid Conditions / Features Associated With The Disease
- Methodology For Quantification Of Patient Numbers
- Top-Line Prevalence For Refractive Errors
- Hyperopia
- Myopia
- Presbyopia
- Features Of Refractive Error Patients
- Hyperopia
- Myopia
- Presbyobia
- Abbreviations Used In The Report
- Other Services & Solutions
- Reports & Publications
- Online Epidemiology Databases
- Online Pharmaceutical Pricing Database
- References
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/lsb4jw/refractive_errors?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Anta Sports Expands Global Footprint With Strategic Puma Stake
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



